BiomX Inc. COmmon Stock (PHGE)

FairStock Score: 13/100 — RISKY

Key Financials

Current Price$0.29
Market Cap$11M
P/E Ratio-0.01
ROE-247.34%
Dividend Yield—%
SectorHealthcare

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I start with durability and a margin of safety. Here, the supplied profile describes a defense and homeland security technology firm, but the financials show a business far from durable. At the close on 2026-10-08, the price was $0.29 and market value was only $10.7 million. In the latest reported quarter, fiscal Q2 2026, revenue was $332,000 and net income was -$3.8 million, a negative 1,136.14% margin. That is not a company funding itself from customers. Trailing free cash flow is -$18.2 million, and FairStock's FCF yield is -169.3% of market cap, so cash burn is enormous relative to the enterprise. The D/E ratio of 0.08 suggests modest debt, but Altman Z-Score of -12.25 and Piotroski F-Score of 1/9 point to severe financial weakness. FairStock's ROE of -247.34% and ROCE of -42.35% tell me capital is being destroyed. Valuation gives no comfort: FairStock's P/E is -0.01, P/B is not available, and the Lynch category is none because only 0 years of filed results are available; I need at least three to judge consistency. The data's profit-growth figure of 37.52% may hint at improvement, but it cannot offset a quarterly margin of -1,136.14%. The 52-week range of $0.12 to $11.97 shows wild volatility, and beta of 1.37 adds market risk. I see no moat in these numbers—only a tiny revenue base, heavy losses, negative cash flow, and a 13/100 FairStock score. Without evidence of self-sustaining economics, the equity is speculative.

In plain English: The provided profile describes a company that develops defense, homeland security, and critical infrastructure technology, including threat detection and counter-drone systems. It is very small: in the latest reported quarter, fiscal Q2 2026, revenue was $332,000 and net income was -$3.8 million, so the business is losing far more than it brings in. The stock price of $0.29 as of 2026-10-08 may look low, but versus the weak numbers shown it does not look like a bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-08 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer